Lithium Oversupply And Chile Policy Will Squeeze Margins

Key Takeaways

• Rising lithium supply, regulatory barriers in Chile, and battery technology shifts put pressure on SQM's pricing power, margins, and long-term revenue outlook.
  
• Environmental, tax, and concession risks threaten access to key resources, increase costs, and create major uncertainty over future profitability and project viability.
  
• Accelerating demand for lithium and iodine, international expansion, and business diversification position SQM for sustained profit growth and resilience, while regulatory risk appears manageable.

Catalysts

Operates as a mining company worldwide.

• Rapid global growth in lithium supply from new projects in Australia, Africa, and North America is expected to persist, which significantly increases the risk of long-term price erosion and margin compression for Sociedad Química y Minera de Chile, potentially leading to sharply lower revenue and earnings power even if SQM is able to raise volumes.
  
• Intensifying government intervention in Chile-including higher royalties, taxes, and a new national lithium policy-will likely erode SQM's net margins and restrict free cash flow, especially as large-scale, capital-intensive projects like Salar Futuro require higher up-front investment and face extended regulatory timelines.
  
• Key lithium concessions in Chile, particularly in the Salar de Atacama, are set to be renegotiated or expire post-2030, directly threatening SQM's access to its highest-margin resources and introducing major uncertainty around long-term supply, future capital needs, and the company's top-line stability.
  
• Structural advances in battery technology, such as the adoption of sodium-ion and other lithium-free chemistries, threaten to shrink the addressable market for newly mined lithium beyond 2030 and could severely impact SQM's volume growth outlook, causing revenues and margins to fall meaningfully below current expectations.
  
• Heightened environmental restrictions, increasing water scarcity, and more stringent permitting in the Atacama region will raise SQM's compliance and operating costs substantially over the coming decade, likely forcing additional capital expenditures and weighing on earnings and investment returns regardless of realized pricing.

Sociedad Química y Minera de Chile Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on Sociedad Química y Minera de Chile compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming Sociedad Química y Minera de Chile's revenue will grow by 11.9% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from 15.4% today to 21.2% in 3 years time.
• The bearish analysts expect earnings to reach $1.6 billion (and earnings per share of $5.49) by about July 2029, up from $815.3 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $3.5 billion.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 12.0x on those 2029 earnings, down from 24.5x today. This future PE is lower than the current PE for the US Chemicals industry at 25.0x.
• The bearish analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.35%, as per the Simply Wall St company report.

Risks

• Accelerating global electric vehicle adoption and strong demand growth in battery energy storage are driving rapid increases in lithium demand, which has already led to a recent recovery in lithium prices and is expected to push SQM's lithium sales volumes and realized prices higher, with a direct positive impact on revenue and profit margins.
  
• SQM continues to expand its lithium production capacity both in Chile and internationally, evidenced by the successful ramp-up of its Australian assets and ongoing investments in new production and refining facilities, which position the company to capture a larger share of growing market demand and support robust long-term revenue growth.
  
• The iodine business remains highly profitable, with solid margins (57% gross margin cited for the latest quarter), and new applications-such as increased use in x-ray contrast media-are supporting sustained strong demand at premium prices and prompting ongoing SQM investment in capacity, backing multi-year gross profit and earnings resilience.
  
• Diversification across specialty plant nutrition, potassium derivatives, and iodine means SQM is not solely reliant on lithium, providing revenue and earnings stability even as individual commodity markets fluctuate, as shown by consistent profitability in plant nutrition and specialty products segments.
  
• The outlook for regulatory approval and partnership with Codelco in Chile is positive, with management expressing confidence in timely resolution and project advancement, which reduces policy overhang risk and enables execution on major growth projects, supporting long-term capital investment and free cash flow generation.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Sociedad Química y Minera de Chile is $52.19, which represents up to two standard deviations below the consensus price target of $85.72. This valuation is based on what can be assumed as the expectations of Sociedad Química y Minera de Chile's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $110.0, and the most bearish reporting a price target of just $44.35.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $7.4 billion, earnings will come to $1.6 billion, and it would be trading on a PE ratio of 12.0x, assuming you use a discount rate of 8.4%.
• Given the current share price of $69.81, the analyst price target of $52.19 is 33.8% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.